FDA Approval: YERVOY (IPILIMUMAB) — Type 1 - New Molecular Entity
Policy FDA-BLA125377 · Oncology
Yervoy (ipilimumab) is an injectable drug that may be assigned a J-code for Medicare billing, as it qualifies for Part B coverage due to its injectable nature. It is an orphan drug, which could indica